The Effects of Luo-Bu-Fu-Ke-Bi-RI Pill

Completed

• Conditions: Climacteric Syndrome
• Interventions: Drug: Luo-Bu-Fu-Ke-Bi-RI Pill; Drug: tibolone

• Registration Number: NCT05846698
• Lead Sponsor: Guoqing Zhou

Brief Summary

To investigate the effect of LBFKBRP on climacteric syndrome in women and explore its therapeutic mechanism.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-07-01
• Primary Completion: 2020-12-31
• Study Completion: 2021-12-31
• Study First Submitted: 2023-04-11
• Study First Submitted QC: 2023-04-26
• Study First Posted: 2023-05-06
• Status Verified: 2023-08
• Last Update Submitted: 2023-08-22
• Last Update Posted: 2023-08-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 276

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
treatment group	Luo-Bu-Fu-Ke-Bi-RI Pill	-
control group	tibolone	-

Primary Outcome Measures

Name	Time	Method
Sex hormone	3 month

Trial Locations

Locations (1)

The First Affiliated Hospital of Chongqing Medical University; 🇨🇳 Chongqing, Chongqing, China